Header Logo

Connection

Mark Pollack to Imipramine

This is a "connection" page, showing publications Mark Pollack has written about Imipramine.
Connection Strength

0.248
  1. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
    View in: PubMed
    Score: 0.119
  2. Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994 May; 55(5):200-5.
    View in: PubMed
    Score: 0.030
  3. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
    View in: PubMed
    Score: 0.028
  4. Verapamil in the treatment of recurrent unipolar depression. Biol Psychiatry. 1987 Jun; 22(6):779-82.
    View in: PubMed
    Score: 0.019
  5. Treatment-emergent incontinence with lithium. J Clin Psychiatry. 1985 Oct; 46(10):444-5.
    View in: PubMed
    Score: 0.017
  6. EFFECTS OF CHLORPROMAZINE AND IMIPRAMINE ON SYSTOLIC BLOOD PRESSURE IN PSYCHIATRIC PATIENTS: RELATIONSHIPS TO AGE, DIAGNOSIS AND INITIAL BLOOD PRESSURE. J Psychiatr Res. 1964 Jan; 2:51-60.
    View in: PubMed
    Score: 0.015
  7. Clinical issues in the long-term treatment of panic disorder. J Clin Psychiatry. 1996; 57 Suppl 10:44-8; discussion 49-50.
    View in: PubMed
    Score: 0.008
  8. Pattern of placebo response in panic disorder. Psychopharmacol Bull. 1995; 31(2):273-8.
    View in: PubMed
    Score: 0.008
  9. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull. 1987; 23(1):182-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.